Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

M. Tanaka; M. Asada; A.Y. Higashi; J. Nakamura; A. Oguchi; M. Tomita; S. Yamada; N. Asada; M. Takase; T. Okuda; H. Kawachi; A.N. Economides; E. Robertson; S. Takahashi; T. Sakurai; R. Goldschmeding; E. Muso; A. Fukatsu; T. Kita; M. Yanagita

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

M. Tanaka
, M. Asada
, A.Y. Higashi
, J. Nakamura
, A. Oguchi
, M. Tomita
, S. Yamada
, N. Asada
, M. Takase
, T. Okuda
, H. Kawachi
, A.N. Economides
, E. Robertson
, S. Takahashi
, T. Sakurai
, R. Goldschmeding
, E. Muso
, A. Fukatsu
, T. Kita
, M. Yanagita

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	768-777
Number of pages	10
Journal	Journal of Clinical Investigation
Volume	120
Issue number	3
Publication status	Published - 2010

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/20197625

Cite this

Tanaka, M., Asada, M., Higashi, A. Y., Nakamura, J., Oguchi, A., Tomita, M., Yamada, S., Asada, N., Takase, M., Okuda, T., Kawachi, H., Economides, A. N., Robertson, E., Takahashi, S., Sakurai, T., Goldschmeding, R., Muso, E., Fukatsu, A., Kita, T., & Yanagita, M. (2010). Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. Journal of Clinical Investigation, 120(3), 768-777. http://www.ncbi.nlm.nih.gov/pubmed/20197625

@article{d4c8eee566c44fc99befa975bc1ed436,

title = "Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.",

author = "M. Tanaka and M. Asada and A.Y. Higashi and J. Nakamura and A. Oguchi and M. Tomita and S. Yamada and N. Asada and M. Takase and T. Okuda and H. Kawachi and A.N. Economides and E. Robertson and S. Takahashi and T. Sakurai and R. Goldschmeding and E. Muso and A. Fukatsu and T. Kita and M. Yanagita",

year = "2010",

language = "English",

volume = "120",

pages = "768--777",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "3",

}

Tanaka, M, Asada, M, Higashi, AY, Nakamura, J, Oguchi, A, Tomita, M, Yamada, S, Asada, N, Takase, M, Okuda, T, Kawachi, H, Economides, AN, Robertson, E, Takahashi, S, Sakurai, T, Goldschmeding, R, Muso, E, Fukatsu, A, Kita, T & Yanagita, M 2010, 'Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.', Journal of Clinical Investigation, vol. 120, no. 3, pp. 768-777. <http://www.ncbi.nlm.nih.gov/pubmed/20197625>

TY - JOUR

T1 - Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

AU - Tanaka, M.

AU - Asada, M.

AU - Higashi, A.Y.

AU - Nakamura, J.

AU - Oguchi, A.

AU - Tomita, M.

AU - Yamada, S.

AU - Asada, N.

AU - Takase, M.

AU - Okuda, T.

AU - Kawachi, H.

AU - Economides, A.N.

AU - Robertson, E.

AU - Takahashi, S.

AU - Sakurai, T.

AU - Goldschmeding, R.

AU - Muso, E.

AU - Fukatsu, A.

AU - Kita, T.

AU - Yanagita, M.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0021-9738

VL - 120

SP - 768

EP - 777

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 3

ER -